Uncategorized

Biotech Zooms Into Breakout Zone On Hard-Fought Approval – Investor’s Business Daily

Posted on Author Tim Hodges Comments Off on Biotech Zooms Into Breakout Zone On Hard-Fought Approval – Investor’s Business Daily
  1. Biotech Zooms Into Breakout Zone On Hard-Fought Approval  Investor’s Business Daily
  2. Soleno Therapeutics Announces U.S. FDA Approval of VYKAT(TM) XR to Treat Hyperphagia in Prader-Willi Syndrome  GlobeNewswire
  3. Soleno Therapeutics’ ‘life-changing’ rare-disease drug approved | STAT  STAT
  4. US FDA approves first treatment for rare genetic disorder Prader-Willi syndrome  Reuters
  5. Drugmaker Soleno Soars on Approval to Treat Never Ending Hunger  Yahoo Finance